Competitor Analysis: Tuberculosis Vaccines and Therapeutics

Competitor Analysis: Tuberculosis Vaccines and Therapeutics

Product description

The present Competitive Intelligence Report about Tuberculosis Vaccines & Therapeutics provides a competitor evaluation in the field of prophylactic vaccines and therapeutic small molecules and peptides against infection with Mycobacterium tuberculosis as of September 2012. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The WHO estimates that the largest number of new tuberculosis (TB) cases in 2008 occurred in the South-East Asia Region, which accounted for 34% of incident cases globally. However, the estimated incidence rate in sub-Saharan Africa is nearly twice that of the South-East Asia Region with over 350 cases per 100 000 population. An estimated 1.3 million people died from TB in 2008. The highest number of deaths was in the South-East Asia Region, while the highest mortality per capita was in the Africa Region. Until 50 years ago, there were no medicines to cure TB. Now, strains that are resistant to a single drug have been documented in every country surveyed; what is more, strains of TB resistant to all major anti-TB drugs have emerged. Drug-resistant TB is caused by inconsistent or partial treatment. A particularly dangerous form of drug-resistant TB is multidrug-resistant TB (MDR-TB), which is defined as the disease caused by TB bacilli resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.
Private-public partnerships have considerably contributed to establish a tuberculosis vaccine and drug pipeline. So far, there is no approved vaccine for tuberculosis. Now, several vaccines are in clinical development and further in preclinical stages. Small molecule therapeutics are also in clinical and preclinical development and significant research efforts are being undertaken to discover novel small molecule therapeutics with a mechanism of action different from currently used treatments.
The report includes a compilation of currently active projects in development of vaccines and small molecules and peptides targeting Mycobacterium tuberculosis for prophylaxis and treatment of tuberculosis. In addition, the report lists corporate and public R&D pipelines of Tuberculosis Vaccines & Therapeutics. Competitor projects are listed in a tabular format providing information on:

• Drug Codes,
• Target / Mechanism of Action,
• Class of Compound,
• Company,
• Product Category,
• Indication,
• R&D Stage and
• additional comments with a hyperlink leading to the source of information.
  

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

All Reports by This Publisher http://www.marketresearchreports.biz/publisher/83

Antidepressants Market to 2018 - Despite Safety Concerns, Selective Serotonin Re-uptake Inhibitors (SSRIs) Continue to Dominate in the Absence of Effective Therapeutic Alternatives

Antidepressants Market to 2018 - Despite Safety Concerns, Selective Serotonin Re-uptake Inhibitors (SSRIs) Continue to Dominate in the Absence of Effective Therapeutic Alternatives

Antidepressants Market

Antidepressants Market to 2018 Despite Safety Concerns, Selective Serotonin Re-uptake Inhibitors (SSRIs) Continue to Dominate in the Absence of Effective Therapeutic Alternatives

GBI Research, the leading business intelligence provider, has released its latest research, Antidepressants Market to 2018 Despite Safety Concerns, Selective Serotonin Re-uptake Inhibitors (SSRIs) Continue to Dominate in the Absence of Effective Therapeutic Alternatives, which provides insights into the antidepressants market until 2018. The report is built using data sourced from our proprietary databases and primary and secondary research, in addition to analysis from our in-house specialized team of experts. The report provides an in-depth analysis of the major antidepressants therapies, including SSRIs, Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) and Tricyclic Antidepressants (TCAs), covering Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Generalized Anxiety Disorder (GAD) and Panic Disorder (PD). The report provides the sales for the global antidepressant market in addition to the individual indication markets. It also examines the global antidepressant market treatment usage patterns, in addition to the geographical distribution of antidepressants across the US, the top five countries of Europe, and Japan. The report also includes insights into the antidepressants R&D product pipeline and explores the competitive landscape, including major players in the antidepressants market. Finally, the report also includes analysis on the Mergers and Acquisitions (M&As) and licensing agreements that took place in antidepressant market. 

GBI Research analysis shows that the overall global antidepressant market for the four indications, (MDD, OCD, GAD and PD) was valued at $11.9 billion in 2011, growing from $10.5 billion in 2004 and indicating a Compounded Annual Growth Rate (CAGR) of 1.7%. The market is forecast to reach revenues of approximately $13.4 billion by 2018 for the above mentioned four major indications, increasing at a CAGR of 1.8%. Overall the number of prescriptions for antidepressant has risen, but this has been offset by a number of patent expiries and high generic entry. Drugs currently in development have taken on a new multi-targeted approach, combining targets known to be beneficial for the treatment of MDD, OCD, GAD and PD. The future of the antidepressant market is reliant on the positive safety profiles of drugs in the pipeline, with no disease-modifying therapies expected to enter the market in the near future.

Scope

• The report analyzes the treatment usage patterns, market characterization, pipeline analysis, competitive landscape and key M&A trends in the global antidepressant market for MDD, OCD, GAD and PD.
• Data and analysis on the antidepressant market in the leading geographies of the world the US, the UK, Germany, France, Italy, Spain, and Japan. 
• Annualized market data for the antidepressant market from 2004 to 2011, with forecasts to 2018.
• Market data on the geographical landscape and therapeutic landscape, including market size, market share, annual cost of therapy, sales volume and treatment usage patterns (diseased population, diagnosis population and prescription population).
• Key drivers and restraints that have had a significant impact on the market.
• The competitive landscape of the global antidepressant market including top company benchmarking. The key companies studied in this report are Eli Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Forest laboratories and Lundbeck. 
• Key M&A activities and licensing agreements that took place between 2009 and 2012 in the antidepressants therapeutics market.

Reasons to buy

• Align their product portfolio to markets with high growth potential. 
• Build effective strategies to launch their pipeline products by identifying potential geographies. 
• Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps. 
• Develop key strategic initiatives by studying the key strategies of top competitors. 
• Device a more tailored country strategy through the understanding of key drivers and barriers and the market potential of each indication. 
• Develop market entry and market expansion strategies by identifying the geographic markets poised for strong growth. 
• Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules which are safer and more efficacious.

 Antidepressants Market to 2018 - Despite Safety Concerns, Selective Serotonin Re-uptake Inhibitors (SSRIs) Continue to Dominate in the Absence of Effective Therapeutic Alternatives

Antidepressants Market

Table of Contents

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 9
1.2 List of Figures 10

Shale Market in North America
Offshore Drilling Industry in Asia-Pacific
Offshore Drilling Industry in the Americas
Biodefense Industry
Pathways to Efficient Drug Development
Engaging Key Opinion Leaders (KOLs)
LED and LED Driver IC Markets
Semiconductors in the Patient Monitoring Systems Market        

 

2 Antidepressants Market to 2018 - Introduction 12

3 Market Overview 13
3.1 Introduction 13
3.2 Classification of Antidepressants 14
3.2.1 Selective Serotonin Reuptake Inhibitors 15
3.2.2 Serotonin-Norepinephrine Reuptake Inhibitors 15
3.2.3 Noradrenergic and Specific Serotonergic Antidepressants 15
3.2.4 Norepinephrine Reuptake Inhibitors 16
3.2.5 Norepinephrine-Dopamine Reuptake Inhibitors 16
3.2.6 Norepinephrine-Dopamine Disinhibitors 16
3.2.7 Serotonin Antagonist and Reuptake Inhibitors 16
3.2.8 Tricyclic Antidepressants 16
3.2.9 Tetracyclic Antidepressants 17
3.2.10 Monoamine Oxidase Inhibitors 17
3.2.11 Others 18
3.3 Adverse Effects 18
3.4 Major Marketed Products in the Antidepressants Therapy Area 18
3.5 Future Developments 20
3.6 Revenue 21
3.7 Annual Cost of Therapy 23
3.8 Treatment Usage Patterns 24
3.8.1 Diseased Population 25
3.8.2 Diagnosed Population 25
3.8.3 Prescription Population 25
3.9 Drivers and Restraints of the Antidepressants Market 26
3.9.1 Drivers 26
3.9.2 Restraints 27

4 Therapeutic Landscape 284.1 Antidepressants Market for Major Depressive Disorder 28
4.1.1 Introduction 28
4.1.2 Revenue and Forecasts 30
4.1.3 Annual Cost of Therapy 31
4.1.4 Treatment Usage Patterns 32
4.1.5 Geographical Segmentation 33
4.2 Drivers and Restraints for the Antidepressants Market for Major Depressive Disorder 35
4.2.1 Drivers 35
4.2.2 Restraints 35
4.3 Antidepressants Market for Obsessive-Compulsive Disorder 37
4.3.1 Introduction 37
4.3.2 Revenue and Forecasts 39
4.3.3 Annual Cost of Therapy 40
4.3.4 Treatment Usage Patterns 41
4.3.5 Geographical Segmentation 42
4.4 Drivers and Restraints for the Antidepressants Market for Obsessive-Compulsive Disorder 44
4.4.1 Drivers 44
4.4.2 Restraints 44
4.5 Antidepressants Market for Generalized Anxiety Disorder 45
4.5.1 Introduction 45
4.5.2 Revenue and Forecasts 46
4.5.3 Annual Cost of Therapy 48
4.5.4 Treatment Usage Patterns 49
4.5.5 Geographical Segmentation 51
4.6 Drivers and Restraints for the Antidepressants Market for Generalized Anxiety Disorder 54
4.6.1 Drivers 54
4.6.2 Restraints 54
4.7 Antidepressants Market for Panic Disorder 55
4.7.1 Introduction 55
4.7.2 Revenue and Forecasts 58
4.7.3 Annual Cost of Therapy 59
4.7.4 Treatment Usage Patterns 60
4.7.5 Geographical Segmentation 62
4.8 Drivers and Restraints for the Antidepressants Market for Panic Disorder 64
4.8.1 Drivers 64
4.8.2 Restraints 64

5 Geographical Landscape 66
5.1 The US 67
5.1.1 Revenue and Forecasts 67
5.1.2 Annual Cost of Therapy 69
5.1.3 Treatment Usage Patterns 70
5.2 EU5 72
5.2.1 Revenue and Forecasts 72
5.2.2 Annual Cost of Therapy 73
5.2.3 Treatment Usage Patterns 74
5.3 Japan 75
5.3.1 Revenue and Forecasts 75
5.3.2 Annual Cost of Therapy 76
5.3.3 Treatment Usage Patterns 77

Pharmaceutical Pricing and Reimbursement
Diabetes Care Devices Market
Polyvinyl Chloride (PVC) Global Market
Active Pharmaceutical Ingredients (API) Market in the Americas
Substance Abuse Therapeutics Market
Cloud Computing in Pharmaceutical Research and Development
Clinical Supply Chain Management
Emerging Power Markets in Eastern Europe to 2020

 

6 Pipeline Analysis 79
6.1 Introduction 79
6.2 Summary of the Current Antidepressants R&D Pipeline 79
6.3 Profiles of Key Late-Stage Drugs in the Antidepressants Market 82
6.3.1 Vortioxetine (Lu AA21004) 82
6.3.2 F-2695 (levomilnacipran) 83
6.3.3 LY-2216684 (edivoxetine) 84
6.3.4 OPC-34712 84
6.3.5 EB-1010/Amitifadine 85
6.3.6 PNB01 86

7 Competitive Landscape 87
7.1 Competitive Profiling 87
7.1.1 H. Lundbeck 87
7.1.2 AstraZeneca 88
7.1.3 Eli Lilly and Company 89
7.1.4 Forest Laboratories 90
7.1.5 Pfizer Inc. 92
7.1.6 GlaxoSmithKline 93
7.1.7 Bristol-Myers Squibb Company 94

8 Strategic Consolidations 968.1 Merger and Acquisition Deals 96
8.1.1 Paladin Labs Completes Acquisition of Labopharm 96
8.1.2 High River Acquires 6.5% Stake in Forest Laboratories 96
8.1.3 Forest Laboratories Completes Acquisition of Clinical Data 96
8.1.4 Azur Pharma Completes Merger with Jazz Pharmaceuticals in All Stock Transaction 97
8.1.5 Nuvo Research Acquires ZARS Pharma 97
8.1.6 Sun Pharmaceutical Acquires Remaining 24% Stake of Caraco Pharmaceutical 98
8.2 Licensing Agreements 98
8.2.1 Labopharm Enters into Licensing Agreement with Angelini Group for OLEPTRO 98
8.2.2 Omeros Expands Licensing Agreement with Daiichi Sankyo 98
8.2.3 Jazz Pharmaceuticals Enters into Sub-Licensing Agreement with Anchen 98
8.2.4 AstraZeneca Enters into Collaboration and Licensing Agreement with Targacept 99
8.2.5 Indevus Pharmaceuticals Enters into Licensing Agreement with Teva Pharmaceutical 99
8.2.6 Impax Laboratories Enters into Licensing Agreement with Wyeth 99
8.2.7 Mylan Enters into Licensing Agreement with GlaxoSmithKline 99
8.2.8 Tikvah Therapeutics Signs Licensing Agreement with Therapade Technologies 99
8.2.9 GlaxoSmithKline Signs an Agreement with Fabre-Kramer Pharmaceuticals 100
8.2.10 Jazz Pharmaceuticals Enters into Licensing Agreement with Solvay 100
8.2.11 Targacept Enters into Licensing Agreement with Yale University 100
8.3 Co-Development Deals 100
8.3.1 Lundbeck Enters into Co-Development Agreement with Otsuka Pharmaceutical 100
8.3.2 Eli Lilly Terminates Co-Development Agreement with Boehringer Ingelheim 101
8.3.3 Lundbeck Enters into Co-Development Agreement with Takeda 101

Power Management Integrated Circuits (IC) Market
Hearing Aid Devices Market
Renewable Energy Market in South and Central America
Energy-efficient Lighting Market in Europe
Accelerating Drugs to Market
Innovations in Drug Delivery
Surgical Equipment Market to 2018

9 Appendix 102
9.1 Market Definitions 102
9.2 Abbreviations 102
9.3 Sources 104
9.4 Research Methodology 105
9.4.1 Coverage 105
9.4.2 Secondary Research 105
9.4.3 Primary Research 106
9.5 Therapeutic Landscape 107
9.5.1 Epidemiology-based Forecasting 107
9.5.2 Market Size by Geography 109
9.6 Geographical Landscape 110
9.7 Pipeline Analysis 110
9.8 Competitive Landscape 110
9.8.1 Expert Panel Validation 110
9.9 Contact Us 110
9.10 Disclaimer 110

Table 1: Global Antidepressants Market, Marketed Products, 2012 19
Table 2: Antidepressants Market, Global, Revenue ($bn), 20042011 21
Table 3: Antidepressants Market, Global, Revenue Forecast ($bn), 20112018 22
Table 4: Antidepressants Market, Global, Annual Cost of Therapy ($), 20042011 23
Table 5: Antidepressants Market, Global, Annual Cost of Therapy ($), 20112018 23
Table 6: Antidepressants Market, Global, Treatment Usage Patterns (millions), 20042011 24
Table 7: Antidepressants Market, Global, Treatment Usage Patterns (millions), 20112018 24
Table 8: Antidepressants Market, MDD, Global, Revenue ($bn), 20042011 30
Table 9: Antidepressants Market, MDD, Global, Revenue Forecast ($bn), 20112018 30
Table 10: Antidepressants Market, MDD, Global, Annual Cost of Therapy ($), 20042011 31
Table 11: Antidepressants Market, MDD, Global, Annual Cost of Therapy ($), 20112018 31
Table 12: Antidepressants Market, MDD, Global, Treatment Usage Patterns (millions), 20042011 32
Table 13: Antidepressants Market, MDD, Global, Treatment Usage Patterns (millions), 20112018 32
Table 14: Antidepressants Market, MDD, Global, Market Segmentation by Geography ($bn), 20042011 34
Table 15: Antidepressants Market, MDD, Global, Market Segmentation by Geography ($bn), 20112018 34
Table 16: Common Obsessions and Compulsions in Obsessive-Compulsive Disorder 38
Table 17: Antidepressants Market, Obsessive-Compulsive Disorder, Global, Revenue ($bn), 20042011 39
Table 18: Antidepressants Market, Obsessive-Compulsive Disorder, Global, Revenue Forecast ($bn), 20112018 39
Table 19: Antidepressants Market, Obsessive-Compulsive Disorder, Global, Annual Cost of Therapy ($), 20042011 40
Table 20: Antidepressants Market, Obsessive-Compulsive Disorder, Global, Annual Cost of Therapy ($), 20112018 40
Table 21: Antidepressants Market, Obsessive-Compulsive Disorder, Global, Treatment Usage Patterns (millions), 20042011 41
Table 22: Antidepressants Market, Obsessive-Compulsive Disorder, Global, Treatment Usage Patterns (millions), 20112018 41
Table 23: Antidepressants Market, Obsessive-Compulsive Disorder, Global, Market Segmentation by Geography ($m), 20042011 43
Table 24: Antidepressants Market, Obsessive-Compulsive Disorder, Global, Market Segmentation by Geography ($m), 20112018 43
Table 25: Antidepressants Market, Generalized Anxiety Disorder, Global, Revenue ($bn), 20042011 47
Table 26: Antidepressants Market, Generalized Anxiety Disorder, Global, Revenue Forecast ($bn), 20112018 47
Table 27: Antidepressants Market, Generalized Anxiety Disorder, Global, Annual Cost of Therapy ($), 20042011 48
Table 28: Antidepressants Market, Generalized Anxiety Disorder, Global, Annual Cost of Therapy ($), 20112018 48
Table 29: Antidepressants Market, Generalized Anxiety Disorder, Global, Treatment Usage Patterns (millions), 20042011 50
Table 30: Antidepressants Market, Generalized Anxiety Disorder, Global, Treatment Usage Patterns (millions), 20112018 50
Table 31: Antidepressants Market, Generalized Anxiety Disorder, Global, Market Segmentation by Geography ($m), 20042011 53
Table 32: Antidepressants Market, Generalized Anxiety Disorder, Global, Market Segmentation by Geography ($m), 20112018 53
Table 33: Antidepressants Market, Panic Disorder, Global, Revenue ($m), 20042011 58
Table 34: Antidepressants Market, Panic Disorder, Global, Revenue ($m), 20112018 58
Table 35: Antidepressants Market, Panic Disorder, Global, Annual Cost of Therapy ($), 20042011 59
Table 36: Antidepressants Market, Panic Disorder, Global, Annual Cost of Therapy ($), 20112018 59
Table 37: Antidepressants Market, Panic Disorder, Global, Treatment Usage Patterns (millions), 20042011 60
Table 38: Antidepressants Market, Panic Disorder, Global, Treatment Usage Patterns (millions), 20112018 61
Table 39: Antidepressants Market, Panic Disorder, Global, Market Segmentation by Geography ($m), 20042011 63
Table 40: Antidepressants Market, Panic Disorder, Global, Market Segmentation by Geography ($m), 20112018 63
Table 41: Antidepressants Market, Global, Revenues by Geography ($bn), 20042011 66
Table 42: Antidepressants Market, Global, Revenues by Geography ($bn), 20112018 67
Table 43: Antidepressants Market, The US, Revenue ($bn), 20042011 68
Table 44: Antidepressants Market, The US, Revenue Forecast ($bn), 20112018 68
Table 45: Antidepressants Market, The US, Annual Cost of Therapy ($), 20042011 69
Table 46: Antidepressants Market, The US, Annual Cost of Therapy ($), 20112018 69
Table 47: Antidepressants Market, The US, Treatment Usage Patterns (millions), 20042011 70
Table 48: Antidepressants Market, The US, Treatment Usage Patterns (millions), 20112018 70
Table 49: Antidepressants Market, EU5, Revenue ($bn), 20042011 72
Table 50: Antidepressants Market, EU5, Revenue Forecast ($bn), 20112018 72
Table 51: Antidepressants Market, EU5, Annual Cost of Therapy ($), 20042011 73
Table 52: Antidepressants Market, EU5, Annual Cost of Therapy ($), 20112018 73
Table 53: Antidepressants Market, EU5, Treatment Usage Patterns (millions), 20042011 74
Table 54: Antidepressants Market, EU5, Treatment Usage Patterns (millions), 20112018 74
Table 55: Antidepressants Market, Japan, Revenue ($m), 20042011 76
Table 56: Antidepressants Market, Japan, Revenue ($m), 20112018 76
Table 57: Antidepressants Market, Japan, Annual Cost of Therapy ($), 20042011 77
Table 58: Antidepressants Market, Japan, Annual Cost of Therapy ($), 20112018 77
Table 59: Antidepressants Market, Japan, Treatment Usage Patterns (millions), 20042011 78
Table 60: Antidepressants Market, Japan, Treatment Usage Patterns (millions), 20112018 78
Table 61: Antidepressants Market, Pipeline, 2012 79
Table 62: Lundbeck, Antidepressant Pipeline Products, 2011 87
Table 63: AstraZeneca, Antidepressants Pipeline, 2011 89
Table 64: Eli Lilly and Company, Antidepressants Pipeline, 2011 90
Table 65: Forest Laboratories, MDD, Pipeline Products, 2011 91
Figure 1: Antidepressants Market, Global, Revenue ($bn), 20042018 21
Figure 2: Antidepressants Market, Global, Annual Cost of Therapy ($), 20042018 23
Figure 3: Antidepressants Market, Global, Therapeutic Usage Patterns (millions), 20042018 24
Figure 4: Antidepressants Market, MDD, Global, Revenue ($bn), 20042018 30
Figure 5: Antidepressants Market, MDD, Global, Annual Cost of Therapy ($), 20042018 31
Figure 6: Antidepressants Market, MDD, Global, Treatment Usage Patterns (millions), 20042018 32
Figure 7: Antidepressants Market, MDD, Global, Market Segmentation by Geography ($bn), 20042018 34
Figure 8: Antidepressants Market, Obsessive-Compulsive Disorder, Global, Revenue ($bn), 20042018 39
Figure 9: Antidepressants Market, Obsessive-Compulsive Disorder, Global, Annual Cost of Therapy ($), 20042018 40
Figure 10: Antidepressants Market, Obsessive-Compulsive Disorder, Global, Treatment Usage Patterns (millions), 20042018 41
Figure 11: Antidepressants Market, Obsessive-Compulsive Disorder, Global, Market Segmentation by Geography ($m), 20042018 43
Figure 12: Antidepressants Market, Generalized Anxiety Disorder, Global, Revenue ($bn), 20042018 47
Figure 13: Antidepressants Market, Generalized Anxiety Disorder, Global, Annual Cost of Therapy ($), 20042018 48
Figure 14: Antidepressants Market, Generalized Anxiety Disorder, Global, Treatment Usage Patterns (millions), 20042018 50
Figure 15: Antidepressants Market, Generalized Anxiety Disorder, Global, Market Segmentation by Geography ($m), 20042018 52
Figure 16: Antidepressants Market, Panic Disorder, Global, Revenue ($m), 20042018 58
Figure 17: Antidepressants Market, Panic Disorder, Global, Annual Cost of Therapy ($), 20042018 59
Figure 18: Antidepressants Market, Panic Disorder, Global, Treatment Usage Patterns (millions), 20042018 60
Figure 19: Antidepressants Market, Panic Disorder, Global, Market Segmentation by Geography ($m), 20042018 63
Figure 20: Antidepressants Market, Global, Revenues by Geography ($bn), 20042018 66
Figure 21: Antidepressants Market, The US, Revenue ($bn), 20042018 68
Figure 22: Antidepressants Market, The US, Annual Cost of Therapy ($), 20042018 69
Figure 23: Antidepressants Market, The US, Treatment Usage Patterns (millions), 20042018 70
Figure 24: Antidepressants Market, EU5, Revenue ($bn), 20042018 72
Figure 25: Antidepressants Market, EU5, Annual Cost of Therapy ($), 20042018 73
Figure 26: Antidepressants Market, EU5, Treatment Usage Patterns (millions), 20042018 74
Figure 27: Antidepressants Market, Japan, Revenue ($m), 20042018 75
Figure 28: Antidepressants Market, Japan, Annual Cost of Therapy ($), 20042018 76
Figure 29: Antidepressants Market, Japan, Treatment Usage Patterns (millions), 20042018 77
Figure 30: Antidepressants Market, SWOT Analysis, Lundbeck, 2011 88
Figure 31: Antidepressants Market, SWOT Analysis, AstraZeneca, 2011 89
Figure 32: Antidepressants Market, SWOT Analysis, Eli Lilly and Company, 2011 90
Figure 33: Antidepressants Market, SWOT Analysis, Forest Laboratories, 2011 91
Figure 34: Antidepressants Market, SWOT Analysis, Pfizer Inc., 2011 93
Figure 35: Antidepressants Market, SWOT Analysis, GlaxoSmithKline, 2011 94
Figure 36: Antidepressants Market, SWOT Analysis, Bristol-Myers Squibb, 2011 95
Figure 37: GBI Research Market Forecasting Model 109

Related Reports

Hepatitis C Therapeutics Market
Ophthalmology Therapeutics Market
Dermatology Therapeutics Market
Peripheral Vascular Devices Market
Ultrabooks Market
Butadiene Market in Asia-Pacific
Biopharmaceutical Manufacturing in India
                     

Digital Crosspoint Switches and Mux / DeMux: Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018

WinterGreen Research announces that it has published a new study Digital Crosspoint Switches and Buffers: Market Shares, Strategy, and Forecasts, Worldwide, 2012 to 2018. The 2012 study has 541 pages, 166 tables and figures. Market growth is related to the explosion of digital information and video that needs to be transported over public and private networks. 

Worldwide digital communication and data center communication markets include digital signals for video as well. Digital information may represent data or voice traffic. A large number of protocols particularly those specific to the data center are supported by digital crosspoint switches. Markets are poised to achieve significant growth as equipment manufacturers find ways to design crosspoint switches and buffers into products, giving significant new functionality.

Digital crosspoint switches are used in high rate data transfer situations to support integration of information in data centers and by carriers. Broadcast quality video transport of data on the Internet is evolving new applications including those at every level of the supply chain, creating demand at the high end for crosspoint switches.

High quality, high speed data and video transport is part of the evolution of broadband networks. Data within the data center is being moved to storage devices and through networks. Data is moving across regional and international locations at a more rapid pace.

According to Susan Eustis, lead author of the WinterGreen Research team that prepared the Digital Crosspoint Switches and Buffers market research study, “With breakthrough 10 Gbps port capacity, the next generation digital crosspoint switch devices enable a next generation level of performance and architectural options for higher density system designs. These 10 Gbps devices are used to implement the 40 Gbps and 100 Gbps port capacity. High speed data infrastructure for40 Gbps and 100 Gbps port capacity is being built almost exclusively from 10 Gbps crosspoint switches. The ability to achieve 40 Gbps data transport and routing devices by stringing together 4 10Gbps devices is less expensive than going to a 40 Gbps device.”

Any technology has an adoption curve. Components that start at market prices are subject to economies of scale. They are priced accordingly. Customers have shipments in 1 gig. These devices are getting mature. The price is dropping substantially. The same is happening for 10 Gbps devices.
Companies seem to feel that there is a little life left in the 10 Gbps crosspoint devices due to the recent technology breakthroughs giving some market life to these devices before 25 Gbps and 28 Gbps devices roll into full product release. Full product release is sure to drive prices down for the new units, making it attractive to use smaller crosspoint switches linked together to gain capacity.

Communications semiconductors demand is increasing. Evolving technology for broadband access is increasing data rates. The increase in network traffic is in part because of the Internet and voice over IP. High speed video transport has become more feasible and is being used more.
A quantum increase in the quantity of data that is being transmitted has occurred. Broadband communications networks are supported in part by advanced digital crosspoint switch devices that permit interconnect functioning to be efficient. They are part of an overall market for network infrastructure equipment and communications semiconductors that offer attractive long-term growth prospects.

Networks are moving to embrace a universal Ethernet protocol. As network bandwidth requirements continue to accelerate, more systems require solutions for high-speed signal integrity problems. Crosspoint switch connectivity product lines sell into carrier and enterprise networking applications.
Products address an increasing need to transport signals at ever increasing speed. Units go across fiber, cable, and copper backplane applications. Incumbent telecommunications carriers, integrated communication service providers, cable multiple service operators, and data center managers are among those worldwide who continue to upgrade and expand legacy portions of their networks. The aim is to accommodate new service offerings. A further aim is to reduce operating costs.
The upgrade and expansion cycle requires the development of a variety of new equipment created from advanced semiconductor solutions. The development of new, next-generation networks is an ongoing effort for both service providers and enterprise data centers.

This study illustrates the digital crosspoint switch market driving forces. It describes the principal competitive factors that impact the success of digital crosspoint switches as they are used to provide chips for high speed data integration management solutions. Market opportunities are addressed in the comprehensive market study that lays out strategy considerations in considerable detail: Markets at $260.7 million in 2011 are anticipated to reach $901.1 billion by 2018.

WinterGreen Research is an independent research organization funded by the sale of market research studies all over the world and by the implementation of ROI models that are used to calculate the total cost of ownership of equipment, services, and software. The company has 35 distributors worldwide, including Global Information Info Shop, Market Research.com, Research and Markets, Bloomberg, and Thompson Financial.

Water Treatment Equipment Market Research Reports

Water Treatment Equipment - Africa

This market analysis gives an overview of the actual situation, trends and future outlook of the water treatment equipment market in Africa. The market analysis provides essential market information for decision-makers including:* Overall market value for water treatment equipment in Africa, 2004-2010* Overall market volume for water treatment equipment in Africa, 2004-2010* Market value and volume for water treatment equipment in different African countries (Ethiopia and Morocco)* Forecasts and future outlook of the market till 2016This market analysis answers to questions such as: * What is the size of the water treatment equipment market in Africa and in different African countries?* How the markets have been developing? How does ...

Published Date: Aug 2011
Published By: Global Research & Data Services

Price: $664

Water Treatment Equipment - Americas

This market analysis gives an overview of the actual situation, trends and future outlook of the water treatment equipment market in America. The market analysis provides essential market information for decision-makers including:* Overall market value for water treatment equipment in America, 2004-2010* Overall market volume for water treatment equipment in America, 2004-2010* Market value and volume for water treatment equipment in different American countries (Canada, Chile, Colombia, Ecuador, Mexico, Peru, United States)* Forecasts and future outlook of the market till 2016This market analysis answers to questions such as: * What is the size of the water treatment equipment market in America and in different American countries?* ...

Published Date: Aug 2011
Published By: Global Research & Data Services

Price: $664

Water Treatment Equipment - Asia

This market analysis gives an overview of the actual situation, trends and future outlook of the water treatment equipment market in Asia. The market analysis provides essential market information for decision-makers including:* Overall market value for water treatment equipment in Asia, 2004-2010* Overall market volume for water treatment equipment in Asia, 2004-2010* Market value and volume for water treatment equipment in different Asian countries (Armenia, Azerbaijan, China, Georgia, India, Indonesia, Iran, Japan, Jordan, Kazakhstan, Kyrgyzstan, Malaysia, Oman, Pakistan, Singapore, South Korea, Sri Lanka, Tajikistan, Thailand, Turkey)* Forecasts and future outlook of the market till 2016This market analysis answers to questions such as:

Published Date: Aug 2011
Published By: Global Research & Data Services

Price: $1341

Water Treatment Equipment - Eastern Europe

This market analysis gives an overview of the actual situation, trends and future outlook of the water treatment equipment market in Eastern Europe. The market analysis provides essential market information for decision-makers including:* Overall market value for water treatment equipment in Eastern Europe, 2004-2010* Overall market volume for water treatment equipment in Eastern Europe, 2004-2010* Market value and volume for water treatment equipment in different Eastern European countries (Bulgaria, Czech Republic, Estonia, Greece, Hungary, Latvia, Lithuania, Macedonia, Moldova, Poland, Romania, Slovakia, Slovenia and Ukraine)* Forecasts and future outlook of the market till 2016This market analysis answers to questions such as: * What...

Published Date: Aug 2011
Published By: Global Research & Data Services

Price: $1341

Water Treatment Equipment - Europe

This market analysis gives an overview of the actual situation, trends and future outlook of the water treatment equipment market in Europe. The market analysis provides essential market information for decision-makers including: Overall market value for water treatment equipment in Europe, 2004-2010 Overall market volume for water treatment equipment in Europe, 2004-2010 Market value and volume for water treatment equipment in different European countries (Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Macedonia, Moldova, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Ukraine, United Ki...

Published Date: Aug 2011
Published By: Global Research & Data Services

Price: $2018

Water Treatment Equipment - Global

This market analysis gives an overview of the actual situation, trends and future outlook of the global water treatment equipment market. The market analysis provides essential market information for decision-makers including:* Overall market value for water treatment equipment in the world, 2004-2010* Overall market volume for water treatment equipment in the world, 2004-2010* Market value and volume for water treatment equipment in different countries (Armenia, Australia, Austria, Azerbaijan, Belgium, Bulgaria, Canada, Chile, China, Colombia, Czech Republic, Denmark, Ecuador, Estonia, Ethiopia, Finland, France, Georgia, Germany, Greece, Hungary, India, Indonesia, Iran , Ireland, Italy, Japan, Jordan, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Macedonia, Malaysia, Mexi...

Published Date: Aug 2011
Published By: Global Research & Data Services

Price: $4050

Water Treatment Equipment - Western Europe

This market analysis gives an overview of the actual situation, trends and future outlook of the water treatment equipment market in Western Europe. The market analysis provides essential market information for decision-makers including:* Overall market value for water treatment equipment in Western Europe, 2004-2010* Overall market volume for water treatment equipment in Western Europe, 2004-2010* Market value and volume for water treatment equipment in different Western European countries (Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden and United Kingdom)* Forecasts and future outlook of the market till 2016This market analysis answers to questions such as: * What is th...

Published Date: Aug 2011
Published By: Global Research & Data Services

Price: $1341

Butadiene Market in Asia-Pacific to 2020 - Polybutadiene, Styrene Butadiene Rubber (SBR) and Acrylonitrile Butadiene Styrene (ABS) to Fuel Demand

Butadiene Market in Asia-Pacific to 2020 - Polybutadiene, Styrene Butadiene Rubber (SBR) and Acrylonitrile Butadiene Styrene (ABS) to Fuel Demand

Butadiene Market in Asia-Pacific

Description

Butadiene Market in Asia-Pacific to 2020 - Polybutadiene, Styrene Butadiene Rubber (SBR) and Acrylonitrile Butadiene Styrene (ABS) to Fuel Demand

Summary

GBI Research, the leading business intelligence provider has released its latest research report, Butadiene Market in Asia-Pacific to 2020 - Polybutadiene, Styrene Butadiene Rubber (SBR) and Acrylonitrile Butadiene Styrene (ABS) to Fuel Demand is an in-depth report , which is focused on the demand side of the Asia Pacific butadiene industry. The report provides the reader with detailed analysis and forecasts of the major economic and market trends affecting Asia Pacific butadiene demand in the major countries of the region. It also provides analysis and description of the major drivers and restraints affecting butadiene demand in each region. Asia Pacific butadiene demand is assessed in terms of end-user segments, prices and the competitive landscape, at both the regional and national level. Overall, the report presents a comprehensive analysis of the Asia Pacific butadiene market, covering all major parameters. The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Researchs team of industry experts.

Scope

The report provides in-depth analysis and details of market opportunities and challenges for manufacturers of butadiene in Asia-Pacific. Its scope includes -
- Demand and production of butadiene in Asia-Pacific from 2000 to 2011 and forecasts for nine years to 2020.
- Detailed analysis of the key drivers and restraints for the Asia-pacific butadiene market.
- Demand and production volume analysis and forecast by major countries in the region such as China, Korea, Japan, Taiwan, India, Thailand and Singapore.
- Butadiene demand analysis of by key end use industries in Asia-Pacific and for all the major countries.
- Capacity share analysis by technology and production process for Asia-Pacific and all the major countries.
- Import and Export analysis and forecast for all the major countries of Asia-Pacific.
- Price analysis and forecasts of butadiene for all the major countries of the Asia-Pacific.
- Competitive landscape for Asia-Pacific and for all the major countries.
- The butadiene installed capacity and forecasts to 2016 period for all major countries.

Reasons to buy

- Understand regional market dynamics through detailed demand and production forecasts, end-use data and competitive landscape analysis.
- Understand the differing pricing dynamics in Asia-Pacific and between various countries.
- Understand the drivers and resistors shaping the current and potential future markets.
- Identify key growth markets for products from validated, country-level data and analysis.
- Identify emerging markets and investment opportunities in both general and niche markets.
- Evaluate opportunities in emerging markets to quantify potential returns on investment.
- Develop custom strategies armed with validated historic and forecast data, combined with detailed growth opportunities analysis.
- Make better-informed decisions based on insights and in-depth analysis of market landscapes and the factors shaping them.
- Benchmark different countries by the historic and forecast growth of demand, production and end-use of butadiene.
- Refine business strategies with a fuller understanding of the trends and developments shaping your markets.
- Gain knowledge regarding the market share of each of the major producers in the market in different countries of the Asia-Pacific.